On Monday, April 25th, the Duchenne Community will come together in an overwhelming show of strength at the FDA Advisory Committee meeting with one message: eteplirsen is safe, effective, and deserves approval. We thank the nearly 900 members of our community who made the trip.
For those of you who cannot attend in person, there are several ways in which you can participate from your home and still be a part of the AdComm.
Watch the live stream of the Ad Comm here. Please note that the live coverage will not begin until the meeting begins at 8am EST on Monday, April 25th 2016. The Center for Drug Evaluation and Research (CDER) will provide archived footage of the meeting after the event. Click here to view the FDA’s official notice for more detailed information.
View a draft Agenda of the AdComm Meeting here.